IXIARO 6 MCG / 0.5 ML
INACT.JAPANESE ENCEPHAL VIRUS(ATTENUAT. STRAIN SA14-14-2 PRODUCED IN VERO CELLS) : 6 MCG / 0.5 ML · DIN 02333279 · VALNEVA AUSTRIA GMBH
Health Canada status: MARKETED
What is IXIARO?
IXIARO 6 MCG / 0.5 ML contains INACT.JAPANESE ENCEPHAL VIRUS(ATTENUAT. STRAIN SA14-14-2 PRODUCED IN VERO CELLS) : 6 MCG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02333279, held by VALNEVA AUSTRIA GMBH, supplied as SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 09-Oct-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02333279 |
|---|---|
| Brand name | IXIARO |
| Generic / active ingredient | INACT.JAPANESE ENCEPHAL VIRUS(ATTENUAT. STRAIN SA14-14-2 PRODUCED IN VERO CELLS) : 6 MCG / 0.5 ML |
| Manufacturer | VALNEVA AUSTRIA GMBH |
| Strength | 6 MCG / 0.5 ML |
| Dosage form | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07BA02 ENCEPHALITIS, JAPANESE, INACTIVATED, WHOLE VIRUS |
| AHFS class | 80:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Oct-2013 |
| Original market date | 2009-12-29 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code J07BA02 ENCEPHALITIS, JAPANESE, INACTIVATED, WHOLE VIRUS. 1 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JE-VAX 1 DOSE | 1 UNIT | POWDER FOR SUSPENSION ; KIT | (BIKEN) THE RES.FOUND.FOR MICROB.DIS.OSAKA UNIVERSITY | CANCELLED POST MARKET | DIN 02048744 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.